Steven G. Deeks

San Francisco General Hospital — United States

Immunology and Microbiology · Life Sciences

151h-index81.9kcitations971works12.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(643), HIV/AIDS Research and Interventions(335), HIV/AIDS drug development and treatment(271), Immune Cell Function and Interaction(244), HIV-related health complications and treatments(196)

Publications967 total

Inhibitory potential of autologous neutralizing antibodies sets quantitative limits on the rebound-competent HIV-1 reservoir
2025Open Access
Correlates of HIV-1 control after combination immunotherapy
Nature·2025· 6 citedOpen Access
Increased mannosylation of extracellular vesicles in Long COVID plasma provides a potential therapeutic target for <i>Galanthus nivalis</i> agglutinin (GNA) affinity resin
2025Open Access
Comparison of manual and automated ultrasensitive assays for residual HIV-1 in plasma from individuals on suppressive antiretroviral therapy
Journal of Clinical Microbiology·2025Open Access
Participant Perspectives in an HIV Treatment Interruption Study in San Francisco, United States
AIDS Research and Human Retroviruses·2025· 2 citedOpen Access
Mechanism for evolution of diverse autologous antibodies upon broadly neutralizing antibody therapy of people with HIV
Cell Reports·2025Open Access
Total and HIV-specific T cells from elite controllers preferentially express the follicle homing receptor CXCR5 4472
The Journal of Immunology·2025Open Access
Leveraging virus-specific T cells as antigen biosensors to interrogate the pathogenesis of long COVID 3632
The Journal of Immunology·2025Open Access
How HIV research drives health innovation in multiple diseases
Nature Medicine·2025· 1 cited
Case-control study of autonomic symptoms in the setting of Long COVID with tilt table testing
PLoS ONE·2025Open Access
The impact of acute stress on the HIV reservoir: a prospective interventional trial
Journal of Virus Eradication·2025Open Access
Mild HIV-specific selective forces overlaying natural CD4+ T cell dynamics explain the clonality and decay dynamics of HIV reservoir cells
Cell Systems·2025· 1 citedOpen Access
Sex differences in HIV-1 reservoir cell selection are linked to altered innate immune profiles
Science Translational Medicine·2025· 6 cited
Factors associated with resistance of HIV-1 reservoir viruses to neutralization by autologous IgG antibodies
Journal of Clinical Investigation·2025· 4 citedOpen Access
In vivo detection of antisense HIV-1 transcripts in untreated and ART-treated individuals
Life Science Alliance·2025· 2 citedOpen Access
Antiviral Monocytes Increase Prior to Detectable HIV-1 Rebound Viremia
The Journal of Infectious Diseases·2025· 1 citedOpen Access
Differential decreases in various HIV DNA regions and HIV transcripts after ART initiation during chronic infection
Journal of Virology·2025· 1 citedOpen Access
Phase I Trial to Evaluate the Safety of Intralesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma
JCO oncology advances.·2025Open Access
Achieving the global agenda toward HIV cure calls for establishing a research-for-cure academy in West and Central Africa
Journal of Virus Eradication·2025Open Access
The Immunophenotype and Proviral Landscape of HIV-infected CD4 T Cells During Antiretroviral Therapy
2025· 2 citedOpen Access
page 1 of 49Next →

Frequent Co-authors

Jeffrey N. Martin(15), Peter W. Hunt(14), Daniel C. Douek(10), Frederick Hecht(9), Elizabeth Sinclair(9), Rebecca Hoh(8), Joseph M. McCune(8), Sharon R. Lewin(7), Benigno Rodríguez(6), Michael M. Lederman(6), Janet D. Siliciano(6), Nicolas Chomont(6), Jason M. Brenchley(5), Ronald J. Bosch(5), Robert F. Siliciano(5), Ma Somsouk(5), Alan Landay(4), Gregory D. Kirk(4), Bruce D. Walker(4), Yong Huang(4)